UCB
UCB epilepsy drug reaches regulatory bodies
January 21, 2015Research and Development, Sales and Marketing EMA, FDA, UCB, brivaracetam, epilepsy
UCB has established regulatory milestones for its investigational antiepileptic drug brivaracetam in Europe and the US. The Food and Drug …
New UCB chief starts and expands team
January 13, 2015Sales and Marketing Cimzia, Jean-Christophe Tellier, Neupro, UCB, roch deliveux, vimpat
New UCB chief executive Jean-Christophe Tellier who succeeded Roch Doliveux this year has also welcomed three new members to the …
UCB sells generics business
November 10, 2014Manufacturing and Production, Sales and Marketing Belgium, UCB, generics, kremers urban, us conern
UCB is to sell its US generics business Kremers Urban to two private equity firms in a $1.5 billion deal. …
Bristol-Myers Squibb: following the string of pearls
September 8, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, BMS, GSK, Johanna Mercier, Pfizer, UCB, Yervoy, acquisitions
Bristol-Myers Squibb (BMS) is something of an enigma in the pharma industry. Whilst many of its big pharma peers are …
Pharma firms give researchers access
July 22, 2014Research and Development, Sales and Marketing AstraZeneca, GlaxoSmithKline, Janssen R&D, MRC, Pfizer, Takeda, UCB, lilly, research, virtual library
UK researchers are to gain access to compounds from seven pharma companies in a partnership with the Medical Research Council …
Roche joins forces with PatientsLikeMe
April 8, 2014Medical Communications, Research and Development, Sales and Marketing Novartis, PatientsLikeMe, Roche, UCB, real-word data
PatientsLikeMe has set up a five-year agreement with Genentech, Roche’s biologics arm, to allow the firm access to patients’ real-world …
Sanofi and UCB launch new partnership
March 11, 2014Research and Development, Sales and Marketing Sanofi, UCB, arthritis, autoimmune, partnership
Sanofi and UCB have announced a new partnership that will see the companies research and develop new medicines together. Specifically, …
Biotech industry failed by UK, says UCB
February 27, 2014Research and Development, Sales and Marketing Cimzia, NHS, UCB, biotech, doliveux, tellier, vimpat
The UK biotechnology industry has ‘missed the boat’ and not fulfilled its potential, according to outgoing UCB chief executive Roch …
UCB names next chief executive
February 25, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UCB, tellier
Biopharma firm UCB has confirmed its current chief executive Roch Doliveux is to be replaced by Jean-Christophe Tellier. Tellier (pictured) …
UCB launches online challenge to find new drugs
January 28, 2014Medical Communications UCB, crowdsourcing, innovation challenge, website
UCB has launched its ‘Innovation Challenge’ as it looks to pay members of the public to help develop new drugs. …
UK science future looking brighter – survey
July 12, 2013Research and Development, Sales and Marketing UCB, science
A new survey undertaken by UCB has found that enthusiasm for science in the UK is high, but adds that …
Pfizer, UCB sell plants to smaller drugmakers
May 30, 2013Manufacturing and Production Pfizer, UCB
This week saw two pharma companies offload US manufacturing facilities to contract manufacturing organisations (CMOs), with Pfizer selling a plant …
UCB warns of data ‘voyeurism’
February 27, 2013Research and Development, Sales and Marketing EFPIA, UCB, VBP, transparancy
UCB chief executive Roch Doliveux has attacked the idea of making all clinical trial data publicly available, saying it could …
Pharma manufacturing news in brief
January 14, 2013Manufacturing and Production ADMA, Biotest, Catalent, Emerson, Nanocarrier, Orient Europharma, UCB
Facility news from Orient Europharma/NanoCarrier, Catalent and China Biologic, plus new contracts for Emerson Process Management and Biotest Pharma.
UCB sells Indian production plant to Exemed
November 27, 2012Manufacturing and Production API, Exemed, UCB, vapi
UCB Pharma has signed a deal to sell its manufacturing facility in Vapi, India, to local firm Exemed Pharmaceuticals. The …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
